Cargando…
The clinical impact of ICOS signal in colorectal cancer patients
The inducible T-cell co-stimulator (ICOS) belongs to the B7-CD28 immunoglobulin superfamily, which is currently the subject of intense study due to great successes gained in treatment of different malignancies by disrupting their family members. However, the role of ICOS played in colorectal cancer...
Autores principales: | Zhang, Yan, Luo, Yang, Qin, Shao-Lan, Mu, Yi-Fei, Qi, Yang, Yu, Min-Hao, Zhong, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910717/ https://www.ncbi.nlm.nih.gov/pubmed/27467961 http://dx.doi.org/10.1080/2162402X.2016.1141857 |
Ejemplares similares
-
ATAD2 Overexpression Identifies Colorectal Cancer Patients with Poor Prognosis and Drives Proliferation of Cancer Cells
por: Luo, Yang, et al.
Publicado: (2015) -
Plastic wound protectors decreased surgical site infections following laparoscopic-assisted colectomy for colorectal cancer: A retrospective cohort study
por: Luo, Yang, et al.
Publicado: (2017) -
ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020) -
Transcriptome profile and clinical characterization of ICOS expression in gliomas
por: Wang, Jin, et al.
Publicado: (2022) -
Transmembrane domain-mediated Lck association underlies bystander and costimulatory ICOS signaling
por: Wan, Zurong, et al.
Publicado: (2018)